GSDME and non-small cell lung carcinoma: L 50377 44, piperlongumine 45, and AZD 4635 46 are pyridine-containing molecules with pyroptotic activities that exert their effects on non-small cell lung cancer (NSCLC) by activating GSDME [157, 158].